Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.43 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.43 |
| ▸ | ACHE | P22303 | 3/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | CA1 | P00915 | 2/20 | 0.41 |
| ▸ | CA2 | P00918 | 2/20 | 0.41 |
| ▸ | CA7 | P43166 | 2/20 | 0.41 |
| ▸ | CA9 | Q16790 | 2/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.36 |
| ▸ | CD44 | P16070 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18050326 | 0.75 | CYP1A2 (0.47) | CYP1A2CYP2A6ACHETSHRALDH1A1 | |
| SCHEMBL18050325 | 0.75 | CYP1A2 (0.47) | CYP1A2CYP2A6ACHETSHRALDH1A1 | |
| SCHEMBL1611652 | 0.74 | CYP1A2 (0.32) | CYP1A2CYP2A6TSHR | |
| SCHEMBL16961674 | 0.74 | TSHR (0.50) | CYP1A2CYP2A6TSHRALDH1A1CA1 | |
| SCHEMBL16956053 | 0.74 | TSHR (0.35) | CYP1A2CYP2A6ACHETSHRALDH1A1 | |
| O-Xylene SCHEMBL3260339 | 0.71 | TSHR (0.71) | CYP1A2CYP2A6ACHETSHRALDH1A1 | |
| SCHEMBL102473 | 0.71 | CYP1A2 (0.59) | CYP1A2CYP2A6ACHETSHRALDH1A1 | |
| SCHEMBL476988 | 0.71 | CYP1A2 (0.43) | CYP1A2CYP2A6ACHETSHRALDH1A1 | |
| SCHEMBL1611757 | 0.71 | RAPGEF4 (0.39) | CYP1A2CYP2A6TSHRALDH1A1CA1 | |
| SCHEMBL1249412 | 0.71 | CYP1A2 (0.43) | CYP1A2CYP2A6ACHETSHRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110087034-A1 | Organic Semiconductor Material | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 2011-04-14 | — | — | US | disclosed |
| EP-2248818-A1 | ORGANIC SEMICONDUCTOR MATERIAL | Sumitomo Chemical Company, Limited (JP) | 2010-11-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110087034-A1 | Organic Semiconductor Material | OR10J3, TST, OR51E2 | CYP1A2 125/4885CYP2A6 1465/4885ACHE 3944/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.